GlaxoSmithKline Sets Goals for Net Zero Climate Effect by 2030
03 Novembre 2020 - 09:55AM
Dow Jones News
By Joe Hoppe
GlaxoSmithKline PLC said Tuesday that it has set new
environmental goals of net zero effect on the climate and net
positive effect on nature by 2030.
The British pharmaceutical giant said that over the next decade,
it will invest in measures to reduce environmental harm and in
restoration programs to balance the remaining effect that it cannot
reduce.
New targets have been set across different businesses to
underpin these goals, including 100% renewable electricity usage
and good water stewardship at all of its sites, sustainable
sourcing of all materials and a transition to complete use of
electric vehicles by sales representatives.
The new goals apply principally to GlaxoSmithKline's biopharma
business and portfolio. The consumer healthcare business will also
contribute to goals through the delivery of its own targets.
The new targets align with the most ambitious goals of the Paris
Agreement, the company said.
"Improving the environmental sustainability of our business also
makes us more resilient, protecting our operations, so we can
deliver the products that patients and consumers rely on," Chief
Executive Emma Walmsley said.
Shares at 0820 GMT were up 13.8 pence, or 1.0%, at 1338.6
pence.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
November 03, 2020 03:40 ET (08:40 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024